Navigation Links
Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
Date:11/11/2011

NEW YORK, Nov. 11, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the Lazard Capital Markets 8th Annual Healthcare Conference, being held at the Pierre Hotel in New York City. Mr. Bentsur's presentation is scheduled to take place on Wednesday, November 16, 2011, at 9:00 a.m. ET.

A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevat
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
3. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
4. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
7. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
8. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
9. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
11. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its Dario™ ... segment in Australia .  The Dario was ... and reimbursement approval in that country. 9 ... with diabetes. As a case in point, the news segment ... 13 year old boy with Type 1 diabetes and his ...
(Date:7/29/2015)... York , July 29, 2015 ... Transparency Market Research " Active Pharmaceutical Ingredients (API) Market ... Forecast 2014 - 2020 " the global active pharmaceutical ... 2013 and is anticipated to reach USD 185.9 billion ... the forecast period from 2014 to 2020. ...
(Date:7/29/2015)... 24, 2015 Research and Markets ( ... "Global Wound Care Markets (Twelve Country Analysis: ... Canada, China, India, Brazil, Australia, South Korea)" ... report provides a competitive market summary. The wound ... product offerings and product maturity. Several of the ...
Breaking Medicine Technology:LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5Global Wound Care Markets 2015 2
... and Company (NYSE: LLY ) announced results ... genetic mutations and disable specific signaling pathways that can ... – a JAK2 inhibitor and a Hedgehog inhibitor – ... Research (AACR) 102nd Annual Meeting in Orlando, Fla.   ...
... N.C., April 4, 2011 Cardioxyl Pharmaceuticals, Inc. ... from studies of its lead clinical candidate, CXL-1020, ... Annual Scientific Session & Expo in New Orleans, ... demonstrate CXL-1020,s ability to work independently from other ...
Cached Medicine Technology:Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 2Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 3Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 2Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 3Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 5
(Date:7/29/2015)... ... 29, 2015 , ... According to the Miami Herald on July ... mental health disorders. Acu-detox may begin taking off in the South Florida community as ... addiction. Although acupuncture is not a new practice, it is not widely used, but ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
(Date:7/29/2015)... ... , ... We are privileged to announce that U.S. News & World Report has ... hospital in the nation for 2015-2016. This marks the 21st consecutive year that the USC ... is an honor to be included in the top 10 ophthalmology hospitals by U.S. News ...
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... ... Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a ... bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are ...
(Date:7/29/2015)... Madison, Wis. (PRWEB) , ... July 29, 2015 ... ... enrolled its first two patients in a Clinical Performance Study for the Invisiport ... includes 4.4 and 6 French catheter options, offers a less invasive, patient-friendly alternative ...
Breaking Medicine News(10 mins):Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3
... Hamilton, co-author of Beverly Hills Beauty Secrets: A Prominent Dermatologist and ... 2009), brings you a bolder butt and tighter knees with his ... ... -- Stimulated by the J-LO/Beyonce phenomena, our aesthetic culture appears to ...
... issue of the Journal of Clinical Sleep Medicine ... and fatigue in cancer patients. The results indicate that ... improve both pain and fatigue in this patient population. ... reported having trouble sleeping, with 26 percent reporting moderate ...
... Drugs and radiotherapy given for cancer can cause ... mouth sores, dermatitis, and menopausal symptoms. Around a ... including homeopathic medicines, to try to reduce these ... controlled trials, Cochrane Researchers examined recent evidence for ...
... minimize damage, studies find , , TUESDAY, April 14 (HealthDay ... can be of great benefit in either preventing or treating ... be correlated with a lower risk of having a first ... another team in the Netherlands found that patients with a ...
... IDEXX Laboratories, Inc. (Nasdaq: IDXX ), has ... for Friday, April 24, at approximately 7:00 a.m. (eastern). The ... a.m. (eastern) on that day. Individuals can access a live ... IDEXX Web site, www.idexx.com . An archived ...
... areas for days, weeks , , TUESDAY, April 14 (HealthDay ... be a long-lasting local anesthetic for the treatment of ... The shot may also help patients with chronic pain, ... created the anesthetic by packaging the potent painkiller saxitoxin ...
Cached Medicine News:Health News:New Cosmetic Developments from Beverly Hills 2Health News:Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients 2Health News:Homeopathic medicines: Can they help relieve side-effects of cancer therapy? 2Health News:Acetaminophen, Cholesterol Drugs May Help Fight Stroke 2Health News:Acetaminophen, Cholesterol Drugs May Help Fight Stroke 3Health News:Researchers Create Long-Acting Local Anesthetic 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: